Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Recurrence 4Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Leukemia 3Myelodysplastic Syndromes 2Burkitt Lymphoma 2Blast Crisis 2Sezary Syndrome 1Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hypersensitivity 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1

Interventions

Cytarabine 4Cyclophosphamide 4Amifostine 4Etoposide 3sargramostim 2Voriconazole 2Radiotherapy 2Methotrexate 2pegaspargase 1glucarpidase 1Vincristine 1Silymarin 1Pyridostigmine Bromide 1Prednisolone 1Phenobarbital 1Mitoxantrone 1Methylprednisolone 1Mercaptopurine 1Leucovorin 1Irinotecan 1Ifosfamide 1Idarubicin 1Hydrocortisone 1Filgrastim 1Fibroblast Growth Factor 7 1Epoetin Alfa 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Deoxycytidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Dexrazoxane × Other hematologic neoplasm × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡